رجوع
نطاق اليوم
KWD 22.85
KWD 23.96
نطاق 52 أسبوعًا
KWD 11.09
KWD 23.96
حجم التداول
578,872
متوسط 50 يوم / 200 يوم
KWD 16.72
/
KWD 16.77
الإغلاق السابق
KWD 23.81
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (627 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -136.2 | 0.4 |
| P/B | 24.0 | 2.9 |
| ROE % | -18.2 | 3.7 |
| Net Margin % | -5.8 | 3.9 |
| Rev Growth 5Y % | 38.3 | 10.0 |
| D/E | 0.4 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 25.000
+8.8%
Low: KWD 15.000
High: KWD 35.000
مكرر الربحية المستقبلي
28.7
ربحية السهم المستقبلية
KWD 0.830
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
110 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
KWD 5.865
KWD 5.530 – KWD 6.233
|
410 M | 1 |
| FY2029 |
KWD 4.360
KWD 4.111 – KWD 4.634
|
320 M | 1 |
| FY2028 |
KWD 2.683
KWD 2.020 – KWD 3.419
|
220 M | 3 |
النقاط الرئيسية
Revenue grew 38.33% annually over 5 years — strong growth
Debt/Equity of 0.35 — conservative balance sheet
Generating 10.19M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 66.61%
Capital efficient — spends only 0.42% of revenue on capex
ROIC of 0.15% — low return on invested capital
النمو
Revenue Growth (5Y)
38.33%
Revenue (1Y)104.94%
Earnings (1Y)N/A
FCF Growth (3Y)29.89%
الجودة
Return on Equity
-18.19%
ROIC0.15%
Net Margin-5.75%
Op. Margin0.09%
الأمان
Debt / Equity
0.35
Current Ratio1.57
Interest Coverage0.02
التقييم
P/E Ratio
-136.21
P/B Ratio23.96
EV/EBITDA8472.66
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 104.94% | Revenue Growth (3Y) | 58.96% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38.33% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 79.95M | Net Income (TTM) | -4.60M |
| ROE | -18.19% | ROA | -4.99% |
| Gross Margin | 53.46% | Operating Margin | 0.09% |
| Net Margin | -5.75% | Free Cash Flow (TTM) | 10.19M |
| ROIC | 0.15% | FCF Growth (3Y) | 29.89% |
| Safety | |||
| Debt / Equity | 0.35 | Current Ratio | 1.57 |
| Interest Coverage | 0.02 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -136.21 | P/B Ratio | 23.96 |
| P/S Ratio | 7.84 | PEG Ratio | -7.42 |
| EV/EBITDA | 8472.66 | Dividend Yield | 0.00% |
| Market Cap | 626.72M | Enterprise Value | 610.03M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 79.95M | 39.01M | 31.64M | 21.25M | 21.83M |
| Net Income | -4.60M | -3.82M | -936,000.0 | -9.02M | -1.96M |
| EPS (Diluted) | -0.17 | -0.15 | -0.04 | -0.36 | -0.08 |
| Gross Profit | 42.74M | 23.41M | 21.06M | 14.32M | 19.21M |
| Operating Income | 72,000.0 | -2.60M | -1.19M | -8.26M | -1.50M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 92.11M | 76.12M | 31.74M | 25.03M | 27.47M |
| Total Liabilities | 65.96M | 51.70M | 16.26M | 11.95M | 9.84M |
| Shareholders' Equity | 26.15M | 24.43M | 15.48M | 13.08M | 17.63M |
| Total Debt | 9.25M | 29.92M | 5.40M | 6.52M | 6.70M |
| Cash & Equivalents | 25.94M | 14.94M | 21.39M | 16.31M | 14.41M |
| Current Assets | 60.58M | 41.02M | 26.84M | 20.00M | 23.60M |
| Current Liabilities | 38.49M | 19.95M | 16.24M | 6.46M | 4.56M |